Case Report
Joan Dalmau-Carolà
Abstract
Reports of coincident amyotrophic lateral sclerosis, rheumatoid arthritis, and anti- TNF treatment are scant. We report a new case of a patient with other comorbidities exposed to long-term adalimumab treatment in whom a potential neurotoxic side effect of the drug must be considered. We speculate whether continued exposure after the diagnosis of ALS could explain the severity of her outcome.